Insider Stock Trading History of Sherwin Stephen A


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Sherwin Stephen A since year 2005. The trader's CIK number is 1079462. At the time of this reporting, Sherwin Stephen A is the Director of Neurocrine Biosciences Inc . (stock ticker symbol NBIX). See this page for all insider trading activities at Neurocrine Biosciences Inc .

Note that in the past SHERWIN STEPHEN A also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Sherwin Stephen A since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-02-07 NBIX Neurocrine Biosciences Inc Option Ex 15,000 3.40 51,000
2016-04-14 NBIX Neurocrine Biosciences Inc Option Ex 15,000 3.07 46,050
2015-04-07 NBIX Neurocrine Biosciences Inc Option Ex 15,000 4.76 71,400
2015-03-10 BIIB Biogen Idec Inc Option Ex 6,000 59.82 358,920
2015-03-10 BIIB Biogen Idec Inc Sale 6,000 409.67 2,458,020
2014-12-26 VSTM Verastem, Inc. Buy 2,500 8.56 21,395
2014-04-16 NBIX Neurocrine Biosciences Inc Option Ex 12,000 12.37 148,440
2014-01-02 BIIB Biogen Idec Inc Option Ex 5,500 59.82 329,010
2014-01-02 BIIB Biogen Idec Inc Sale 5,500 279.17 1,535,429
2013-06-03 BIIB Biogen Idec Inc Option Ex 12,825 59.82 767,191
2013-06-03 BIIB Biogen Idec Inc Sale 12,825 233.02 2,988,532
2013-05-23 VICL Vical Inc Buy 7,003 .01 70
2013-03-28 NBIX Neurocrine Biosciences Inc Option Ex 12,000 10.60 127,200
2013-03-22 BIIB Biogen Idec Inc Sale 1,500 176.88 265,320
2012-09-04 BIIB Biogen Idec Inc Sale 2,000 145.90 291,800
2012-06-04 BIIB Biogen Idec Inc Sale 2,500 126.45 316,125
2011-12-19 BIIB Biogen Idec Inc Sale 2,500 110.88 277,200
2005-06-08 CEGE Cell Genesys Inc Buy 2,500 4.96 12,387

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Sherwin Stephen A (Director of Neurocrine Biosciences Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.